Filing Details

Accession Number:
0001209191-14-012764
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-20 21:49:42
Reporting Period:
2014-02-18
Filing Date:
2014-02-20
Accepted Time:
2014-02-20 21:49:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827871 Eagle Pharmaceuticals Inc. EGRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033508 Jay Moorin C/o Proquest Investments, L.p..
2430 Vanderbilt Beach Road, 108-190
Naples FL 34109
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 1,927,986 $0.00 1,966,987 No 4 C Indirect By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 1,028,613 $0.00 2,995,600 No 4 C Indirect By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 850,520 $0.00 3,846,120 No 4 C Indirect By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 569,538 $0.00 4,415,658 No 4 C Indirect By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 21,837 $0.00 4,437,495 No 4 X Indirect By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 333,333 $15.00 4,770,828 No 4 P Indirect By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 62,575 $0.00 62,575 No 4 C Indirect By ProQuest Management LLC Plans
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 9,359 $0.00 71,934 No 4 C Indirect By ProQuest Management LLC Plans
Common Stock, $0.001 Par Value Acquisiton 2014-02-18 357 $0.00 72,291 No 4 X Indirect By ProQuest Management LLC Plans
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By ProQuest Investments IV, L.P.
No 4 C Indirect By ProQuest Investments IV, L.P.
No 4 C Indirect By ProQuest Investments IV, L.P.
No 4 C Indirect By ProQuest Investments IV, L.P.
No 4 X Indirect By ProQuest Investments IV, L.P.
No 4 P Indirect By ProQuest Investments IV, L.P.
No 4 C Indirect By ProQuest Management LLC Plans
No 4 C Indirect By ProQuest Management LLC Plans
No 4 X Indirect By ProQuest Management LLC Plans
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2014-02-18 1,927,986 $0.00 1,927,986 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2014-02-18 1,028,613 $0.00 1,028,613 $0.00
Common Stock Series B-1 Convertible Preferred Stock Disposition 2014-02-18 850,520 $0.00 850,520 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2014-02-18 569,538 $0.00 569,538 $0.00
Common Stock Series C Warrants Disposition 2014-02-18 98,368 $0.00 98,368 $0.00
Common Stock Series B-1 Convertible Preferred Stock Disposition 2014-02-18 62,575 $0.00 62,575 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2014-02-18 9,359 $0.00 9,359 $0.00
Common Stock Series C Warrants Disposition 2014-02-18 1,614 $0.00 1,614 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 X Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 X Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 9,360 Indirect By ProQuest Management LLC
Footnotes
  1. Each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series C Convertible Preferred stock automatically converted into one share of the Issuer's Common Stock on a 6.41-for-1 basis immediately prior to the consummation of the Issuer's initial public offering.
  2. The shares are owned by ProQuest Investments IV, L.P. ("Investments IV"), of which ProQuest Associates IV LLC ("Associates IV") is the general partner. Jay Moorin and Alain Schreiber are managing members of Associates IV. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
  3. In accordance with their terms, the Series C Warrants (the "Warrants") were net exercised at an exercise price of $11.67 immediately prior to closing of the Issuer's initial public offering into shares of common stock.
  4. The shares are held in a ProQuest Management LLC Defined Benefit Pension Plan ("DBPP") FBO Jay Moorin and a ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and for the benefit of certain other individuals. The Reporting Person is a trustee of the ProQuest Management LLC DBPP FBO Jay Moorin and the ProQuest Management LLC Salary Savings Plan FB0 Jay Moorin and for the benefit of certain other individuals. The Reporting Person disclaims beneficial ownership of such securities except for the securities held by ProQuest Management LLC DBPP FBO Jay Moorin and ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and otherwise except to the extent of his pecuniary interest in such securities.
  5. The shares are owned by ProQuest Management LLC ("ProQuest Management"). The Reporting Person is a managing member of ProQuest Management. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
  6. Reflects a 1-for-6.41 reverse stock split, pursuant to which each share of preferred stock became convertible into 1/6.41 of a share of common stock.
  7. The expiration date is not relevant to the conversion of these securities.
  8. In accordance with their terms, the Series C Warrants (the "Warrants") were net exercised immediately prior to consummation of the Issuer's initial public offering into shares of Common Stock on a 6.41-for-1 basis.